Search
Showing results for "1"
Research
An economic case for a vaccine to prevent group A streptococcus skin infectionsA vaccine that prevents GAS cellulitis and other skin infections, in addition to throat infections, would maximise its value and commercial viability
Research
Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with Pneumococcal Conjugate VaccinePPV is immunogenic in 9-month-old children at high risk of pneumococcal infections and does not affect the capacity to produce protective immune responses
News & Events
COVID update Feb 2022Dear families, As cases of Covid-19 increase here in Western Australia, we are working closely with our colleagues in general paediatrics to prepare
Research
Genetic and functional evidence for a locus controlling otitis media at chromosome 10q26.3Otitis media (OM) is a common childhood disease characterised by middle ear effusion and inflammation.
Research
Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic regionThe major burden of disease is in developing and tropical settings where topical antibiotics are impractical and lead to rapid emergence of antimicrobial...
News & Events
Wal-yan respiratory researchers head to Milan to participate in international congressThe Wal-yan Respiratory Research Centre is proud to have a team of researchers taking part in, and contributing to, the outstanding scientific programme of the European Respiratory Society International Congress, taking place in Milan.
News & Events
New Study ‘Plugs’ Digital Intervention for Perinatal Mental HealthNew Study ‘Plugs’ Digital Intervention for Perinatal Mental Health
This project aims to investigate the impact of a non-severe burn injury on children's health for life.
Understanding how families engage with screen technologies and how it may influence child development
News & Events
Top-up funding announced to fast-track clinical trials of Spritz-OMResearchers developing a nasal therapy to prevent childhood ear infections and reduce overuse of antibiotics have received $300,000 in top-up funding.